We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
argenx SE | NASDAQ:ARGX | NASDAQ | Depository Receipt |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
377.25 | 390.78 |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | 0 | 383.34 | USD |
Date | Time | Source | Headline |
---|---|---|---|
20/12/2023 | 17:37 | DJN | Argenx Down Nearly 26%, on Pace for Record Percent Decrease -- Data Talk |
28/11/2023 | 16:16 | DJN | Argenx Down Over 10%, On Track for Largest Percent Decrease Since May 2022.. |
28/11/2023 | 12:03 | DJN | Argenx Shares Down After Vyvgart Study Misses Primary Endpoint |
17/7/2023 | 21:58 | DJN | Argenx Launches $750 Million Global Offering |
17/7/2023 | 16:59 | DJN | Argenx Up Over 30%, on Track for Record High Close -- Data Talk |
17/7/2023 | 16:04 | DJN | Argenx Shares Hit 52-Week High After Positive Vyvgart Hytrulo Trial Results |
17/7/2023 | 12:10 | DJN | Argenx, Zai Lab Shares Rise After Positive Trial Results for Vyvgart.. |
21/6/2023 | 00:09 | DJN | Argenx Says FDA Approves Vyvgart Hytrulo Injection to Treat Neuromuscular.. |
argenx (ARGX) Charts1 Year argenx Chart |
|
1 Month argenx Chart |
Intraday argenx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions